Unlocking the Immune Code: IL-5 Dynamics in BALB/c Mice Spleen Post-Exposure to Klebsiella pneumoniae Pili Protein 65.5 kDa
DOI:
https://doi.org/10.22317/imj.v9i1.1302Keywords:
Klebsiella pneumoniae, vaccine, IL-5, Th2 immune response, Pili proteinAbstract
Objectives
Klebsiella pneumoniae is a Gram-negative pathogen responsible for a range of hospital-acquired infections and is increasingly resistant to antibiotics. This study aimed to evaluate the immunogenic potential of a 65.5 kDa pili protein from K. pneumoniae by assessing its ability to induce Interleukin-5 (IL-5) production in the spleen of BALB/c mice, thereby exploring its suitability as a vaccine candidate.
Methods
Twenty-one BALB/c mice were randomly assigned to three groups: control (PBS), adjuvant only, and pili protein. The animals received three intraperitoneal injections at 14-day intervals. The first dose was given with Complete Freund's Adjuvant (CFA), followed by two doses with Incomplete Freund's Adjuvant (IFA). Fourteen days after the final injection, spleens were collected, and IL-5 levels were measured using enzyme-linked immunosorbent assay (ELISA).
Results
The group immunized with the 65.5 kDa pili protein showed a statistically significant increase in IL-5 levels compared to both the control and adjuvant groups (p < 0.001). This indicates that the pili protein effectively stimulates IL-5 production, a key cytokine in the Th2 immune response pathway.
Conclusion
The 65.5 kDa pili protein of Klebsiella pneumoniae demonstrated the ability to enhance IL-5 production and elicit a Th2-type immune response in BALB/c mice. These findings support its potential as a promising vaccine candidate for preventing K. pneumoniae infections through stimulation of humoral immunity.
References
D. C. Recent advances in the understanding and management of Klebsiella pneu moniae. F1000Research [Internet]. 2017; Available from: https://f1000research.com/articles/6-1760/v1/pdf
Martin RM, Bachman MA. Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae. Front Cell Infect Microbiol [Internet]. 2018 Jan 22 [cited 2024 Sep 2];8(JAN). Available from: https://pubmed.ncbi.nlm.nih.gov/29404282/
P. C. The emerging problems of Klebsiella pneumoniae infections: carbapenem resistance and biofilm formation. FEMS Microbiol Lett. 2016;
Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev [Internet]. 2017 May 1 [cited 2024 May 1];41(3):252–75. Available from: https://pubmed.ncbi.nlm.nih.gov/28521338/
Asri NAM, Ahmad S, Mohamud R, Hanafi NM, Zaidi NFM, Irekeola AA, et al. Global Prevalence of Nosocomial Multidrug-Resistant Klebsiella pneumoniae: A Systematic Review and Meta-Analysis. Antibiotics [Internet]. 2021 Dec 1 [cited 2024 May 19];10(12). Available from: /pmc/articles/PMC8698758/
B. D, I. H, S. B, G. O, B. G, T. A. Mortality markers in nosocomial Klebsiella pneumoniae bloodstream infe ction. Springerplus [Internet]. 2016; Available from: https://springerplus.springeropen.com/track/pdf/10.1186/s40064-016-358 0-8
Lanyu L, Huan H. Risk factors of mortality in bloodstream infections caused by Klebsiel la pneumonia. Medicine (Baltimore). 2017;
J. RC, A. RR, Raquel BL, Jaime EPG, Javier CSC, D. S, et al. Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae inf ections: Systematic review and meta-analysis: Mortality due to KPC Kle bsiella pneumoniae infections. J Infect. 2018;
Christopher GH, E. C, S. R, F. P, R. S, R. K, et al. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pn eumoniae infections. Clin Microbiol Infect [Internet]. 2016; Available from: http://www.clinicalmicrobiologyandinfection.com/article/S1198743X16000 835/pdf
Assoni L, Girardello R, Converso TR, Darrieux M. Current Stage in the Development of Klebsiella pneumoniae Vaccines. Infect Dis Ther [Internet]. 2021 Dec 1 [cited 2025 Jan 27];10(4):2157–75. Available from: https://pubmed.ncbi.nlm.nih.gov/34476772/
Lundberg U, Senn BM, Schuler W, Meinke A, Hanner M. Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae. Hum Vaccin Immunother [Internet]. 2013 [cited 2025 Jan 27];9(3):497–505. Available from: https://pubmed.ncbi.nlm.nih.gov/23250007/
Miller JC, Cross AS, Tennant SM, Baliban SM. Klebsiella pneumoniae Lipopolysaccharide as a Vaccine Target and the Role of Antibodies in Protection from Disease. Vaccines [Internet]. 2024 Oct 1 [cited 2025 Jan 27];12(10). Available from: https://pubmed.ncbi.nlm.nih.gov/39460343/
Prakoeswa FR. Peranan Sel Limfosit Dalam Imunulogi: Artikel Review. J Sains dan Kesehat [Internet]. 2020;2(4):525–37. Available from: http://dx.doi.org/10.25026/JSK.V2I4.212
Http://dx.doi.org/10.26714/magnamed.1.5.2018.50-57 1. Levani Y. PERKEMBANGAN SEL LIMFOSIT B DAN PENANDANYA UNTUK FLOWCYTOMETRY. MAGNA MEDICA Berk Ilm Kedokt dan Kesehat [Internet]. 2019;1(5):50. Available from:, 2. Tsutomu Y, M. S, Y. N, M. K KTA diseases: F bench to clinic C of the discover y of interleukin 5. C [Internet]. 2017; A from: http://manuscript. elsevier. com/S1043466616305695/pdf/S104346661630569. . pd. PERKEMBANGAN SEL LIMFOSIT B DAN PENANDANYA UNTUK FLOWCYTOMETRY. MAGNA MEDICA Berk Ilm Kedokt dan Kesehat [Internet]. 2019;1(5):50. Available from: http://dx.doi.org/10.26714/magnamed.1.5.2018.50-57
Sa’adah AS, Mufida DC, Dini Agustina, Pulong Wijang Pralampita. Effect of Immunization of The Pili Protein 65.5 kDa Klebsiella pneumoniae on IFN-Î3 Levels of Spleen BALB/c Mice. Indones J Trop Infect Dis. 2024 Aug;12(2):92–9.
Agustina D, Mufida DC, Suswati E, Shodikin MA, Hermansyah B, Sa’adah AS, et al. Increased levels of IL-10 in the spleen after induction of pili protein 65.5 kDa Klebsiella pneumoniae. Pharm Educ. 2023;23(4):304–10.
Putra Uta DR, Mufida DC, Sutejo IR, Agustina D, Suswati E, Shodikin MA. Increased levels of IL-4 in the Spleen of BALB/c Mice after 65.5 kDa Pili Protein Klebsiella pneumoniae Immunization. Med Lab Technol J. 2024;10(1):55–62.
Yanagibashi, T., Satoh, M., Nagai, Y., Koike, M., & Takatsu K. Allergic diseases: From bench to clinic - Contribution of the discover y of interleukin-5. Cytokine [Internet]. 2017; Available from: http://manuscript.elsevier.com/S1043466616305695/pdf/S1043466616305695 .pdf
Tsutomu Y, M. I, T. N, Makoto A, Yasuharu W, Y. N, et al. IL-5-producing group 2 innate lymphoid cells promote T cell-independen t IgA production in cooperation with eosinophils. Int Immunol. 2024;
Arato V, Raso MM, Gasperini G, Scorza FB, Micoli F. Prophylaxis and Treatment against Klebsiella pneumoniae: Current Insights on This Emerging Anti-Microbial Resistant Global Threat. Int J Mol Sci [Internet]. 2021 Apr 2 [cited 2025 Feb 25];22(8). Available from: https://pubmed.ncbi.nlm.nih.gov/33919847/
Bayart JL, Douxfils J, Gillot C, David C, Mullier F, Elsen M, et al. Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers. Vaccines [Internet]. 2021 Oct 1 [cited 2025 Feb 25];9(10). Available from: https://pubmed.ncbi.nlm.nih.gov/34696200/
Vaillant AAJ, Sabir S, Jan A. Physiology, Immune Response. StatPearls [Internet]. 2024 Jul 27 [cited 2025 Feb 25]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK539801/
Nakayama T, Hirahara K, Onodera A, Endo Y, Hosokawa H, Shinoda K, et al. Th2 Cells in Health and Disease. Annu Rev Immunol [Internet]. 2017;35(1):53–84. Available from: http://dx.doi.org/10.1146/annurev-immunol-051116-052350
Robinson DS. Th-2 cytokines in allergic disease. Br Med Bull [Internet]. 2000;56(4):956–68. Available from: http://dx.doi.org/10.1258/0007142001903625
Bagnasco D, Ferrando M, Varricchi G, Puggioni F, Passalacqua G, Canonica GW. Anti-Interleukin 5 (IL-5) and IL-5Ra biological drugs: Efficacy, safety, and future perspectives in severe eosinophilic asthma. Front Med [Internet]. 2017 [cited 2025 Feb 24];4(AUG). Available from: https://pubmed.ncbi.nlm.nih.gov/28913336/
Wolterink RGJK, KleinJan A, van Nimwegen M, Bergen I, de Bruijn M, Levani Y, et al. Pulmonary innate lymphoid cells are major producers of IL‐5 and IL‐13 in murine models of allergic asthma. Eur J Immunol [Internet]. 2012;42(5):1106–16. Available from: http://dx.doi.org/10.1002/eji.201142018
Zhu Y, Chen L, Huang Z, Alkan S, Bunting KD, Wen R, et al. Cutting Edge: IL-5 Primes Th2 Cytokine-Producing Capacity in Eosinophi ls through a STAT5-Dependent Mechanism. J Immunol [Internet]. 2004;173(5):2918–22. Available from: http://dx.doi.org/10.4049/jimmunol.173.5.2918
Zhang BZ, Hu D, Dou Y, Xiong L, Wang X, Hu J, et al. Identification and Evaluation of Recombinant Outer Membrane Proteins as Vaccine Candidates Against Klebsiella pneumoniae. Front Immunol [Internet]. 2021 Oct 20 [cited 2025 Feb 25];12. Available from: https://pubmed.ncbi.nlm.nih.gov/34745099/
Dubé JY, McIntosh F, Zarruk JG, David S, Nigou J, Behr MA. Synthetic mycobacterial molecular patterns partially complete Freund’s adjuvant. Sci Rep [Internet]. 2020 Dec 1 [cited 2025 Feb 25];10(1). Available from: https://pubmed.ncbi.nlm.nih.gov/32246076/
Beukema M, Gong S, Al-Jaawni K, de Vries-Idema JJ, Krammer F, Zhou F, et al. Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice. Front Immunol [Internet]. 2023 [cited 2025 Feb 25];14. Available from: https://pubmed.ncbi.nlm.nih.gov/37869002/
Martiñón S, Cisneros A, Villicaña S, Hernández-Miramontes R, Mixcoha E, Calderón-Vargas P. Chemical and Immunological Characteristics of Aluminum-Based, Oil-Water Emulsion, and Bacterial-Origin Adjuvants. J Immunol Res [Internet]. 2019 [cited 2025 Feb 25];2019. Available from: https://pubmed.ncbi.nlm.nih.gov/31205956/
Hou N, Zhang X, Zhao L, Zhao X, Li Z, Song T, et al. A novel chronic stress-induced shift in the Th1 to Th2 response promotes colon cancer growth. Biochem Biophys Res Commun. 2013 Oct 4;439(4):471–6.
Hylander BL, Gordon CJ, Repasky EA. Manipulation of Ambient Housing Temperature To Study the Impact of Chronic Stress on Immunity and Cancer in Mice. J Immunol [Internet]. 2019 Feb 1 [cited 2025 Feb 25];202(3):631–6. Available from: https://pubmed.ncbi.nlm.nih.gov/30670578/
Bucsek MJ, Qiao G, MacDonald CR, Giridharan T, Evans L, Niedzwecki B, et al. β-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8+ T Cells and Undermines Checkpoint Inhibitor Therapy. Cancer Res [Internet]. 2017 Oct 15 [cited 2025 Feb 25];77(20):5639–51. Available from: https://pubmed.ncbi.nlm.nih.gov/28819022/
Estrada LD, Ağaç D, Farrar JD. Sympathetic neural signaling via the β2-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8(+) T-cell effector function. Eur J Immunol [Internet]. 2016 Aug 1 [cited 2025 Feb 25];46(8):1948–58. Available from: https://pubmed.ncbi.nlm.nih.gov/27222010/
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Iraq Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.